Stephen J. Freedland

机构：Cedars-Sinai Medical Center, Durham VA Health Care System, Durham VA Medical Center · ORCID：0000-0002-8104-6419

发表论文 1636 篇 · 总被引 44028 次 · h-index 99

代表论文

• Strategies to Mitigate Breast-related Adverse Events in Patients with High-risk Biochemically Recurrent Prostate Cancer Receiving Enzalutamide Monotherapy: Perspectives and Challenges (2025 · European Urology Focus · 被引 3)
• Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer (2025 · Prostate Cancer and Prostatic Diseases · 被引 2)
• Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End Points (2025 · The Journal of Urology · 被引 2)
• Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age (2025 · European Journal of Cancer · 被引 2)
• Enzalutamide in biochemically recurrent prostate cancer: key findings from subsequent analyses of EMBARK and their implications in clinical practice (2026 · Future Oncology · 被引 1)
• Reply by Authors (2026 · The Journal of Urology · 被引 1)